Juno Therapeutics, Inc.
DelistedCIK 1594864fmd_0GGBWE5GSSCWH67P5VW3CB6WK9Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2014 to Dec 31, 2017, 16 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|
| Total revenues | 0 | 18 | 79 | 112 |
| Realized investment gains (losses) | – | 0 | – | – |
| Research and development | 205 | 205 | 264 | 452 |
| Total operating expenses | 233 | 262 | 335 | 560 |
| Operating income | (233) | (244) | (256) | (448) |
| Other non-operating income (expense) | (11) | 0 | (1) | (4) |
| Income before taxes | (243) | (242) | (256) | (443) |
| Income tax expense | 0 | (3) | (11) | (6) |
| Net income from continuing operations | (243) | (239) | (246) | (437) |
| Net income | (243) | (239) | (246) | (437) |
| Net income to common shareholders | (311) | (239) | (246) | – |